Margarita Romeo Marin

13PUBLICATIONS
86CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersNgā taonga Māori nō mua (Māori artefacts)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 18, 2025
Bevacizumab, Atezolizumab, and Acetylsalicylic Acid in Recurrent, Platinum-Resistant Ovarian Cancer: The EORTC 1508-GCG Phase II Study.

Susana Banerjee, Eleonora Ghisoni, Anita Wolfer

|Sep 18, 2024
Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval >6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial.

Antonio González-Martín, María Jesús Rubio, Florian Heitz

|Feb 23, 2024
Prognostic Value of Lymph Node Ratio in Patients with Uterine Carcinosarcoma.

Rasiah Bharathan, Stephan Polterauer, Martha C Lopez-Sanclemente

|Jan 05, 2024
Polypharmacy and Reversible Drug Induced QT Prolongation in a Patient with Advanced Cancer: Case Report.

Gabriela Cerdà, Joaquim Julià-Torras, Jesús González-Barboteo

|Aug 03, 2023
Reply to Z.R. McCaw et al.

Ursula A Matulonis, Domenica Lorusso, Ana Oaknin

|Aug 01, 2023
Analysis of Tumor Microenvironment Changes after Neoadjuvant Chemotherapy with or without Bevacizumab in Advanced Ovarian Cancer (GEICO-89T/MINOVA Study).

Beatriz Tavira, Teresa Iscar, Luis Manso

Pageof 3

Frequent Collaborators

3 joint publications

Toon Van Gorp

3 joint publications

Nicoletta Colombo

3 joint publications

Ana Oaknin

2 joint publications

Eudald Felip